Response Genetics has developed PCR-based genetics tests—ResponseDX: Lung™, ResponseDX: Colon™, ResponseDX: Gastric™—to help physicians with therapeutic treatment decisions for patients with non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and gastric cancer.
- Rapid turnaround time
- 5–7 days from receipt of sample
- Results from small specimens
- Existing FFPE biopsy specimen used for analysis
- Simple reimbursement
- Standard CPT codes reimbursed by Medicare
- Superior analytical results
- Greater specificity using microdissected tumor tissue
- Comprehensive panels
- Quantitative results from PCR-based tests
Response Genetics will request the patient specimen from pathology, analyze the specimen and return a report to the physician within 5–7 days of receipt of the sample.
Please contact customer service at (888) 700-7110 for additional information.